Shirai T - Search Results

1

Evaluation of the efficacy and safety of the combination of gemcitabine and nedaplatin for elderly patients with advanced non-small-cell lung cancer.

Sugiyama T, Hirose T, Nakashima M, Ishida K, Oki Y, Murata Y, Kusumoto S, Shirai T, Yamaoka T, Okuda K, Ohnishi T, Ohmori T, Adachi M. Sugiyama T, et al. Among authors: shirai t. Oncology. 2011;81(3-4):273-80. doi: 10.1159/000334430. Epub 2011 Nov 26. Oncology. 2011. PMID: 22122886

2

Phase I study of the combination of gemcitabine and nedaplatin for treatment of previously untreated advanced non-small cell lung cancer.

Hirose T, Horichi N, Ohmori T, Shirai T, Sohma S, Yamaoka T, Ohnishi T, Adachi M. Hirose T, et al. Among authors: shirai t. Lung Cancer. 2003 Jan;39(1):91-7. doi: 10.1016/s0169-5002(02)00305-7. Lung Cancer. 2003. PMID: 12499100 Clinical Trial.

3

Patients preferences in chemotherapy for advanced non-small-cell lung cancer.

Hirose T, Horichi N, Ohmori T, Kusumoto S, Sugiyama T, Shirai T, Ozawa T, Ohnishi T, Adachi M. Hirose T, et al. Among authors: shirai t. Intern Med. 2005 Feb;44(2):107-13. doi: 10.2169/internalmedicine.44.107. Intern Med. 2005. PMID: 15750269 Free article.

4

The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer.

Hirose T, Mizutani Y, Ohmori T, Ishida H, Hosaka T, Ando K, Shirai T, Okuda K, Ohnishi T, Horichi N, Kubota H, Adachi M. Hirose T, et al. Among authors: shirai t. Cancer Chemother Pharmacol. 2006 Sep;58(3):361-7. doi: 10.1007/s00280-005-0164-7. Epub 2005 Dec 6. Cancer Chemother Pharmacol. 2006. PMID: 16331494 Clinical Trial.

5

Phase II study of the combination of gemcitabine and nedaplatin for advanced non-small-cell lung cancer.

Shirai T, Hirose T, Noda M, Ando K, Ishida H, Hosaka T, Ozawa T, Okuda K, Ohnishi T, Ohmori T, Horichi N, Adachi M. Shirai T, et al. Lung Cancer. 2006 May;52(2):181-7. doi: 10.1016/j.lungcan.2006.01.004. Epub 2006 Mar 24. Lung Cancer. 2006. PMID: 16563558 Clinical Trial.

6

Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer.

Hirose T, Shirai T, Ishida H, Ando K, Sugiyama T, Kusumoto S, Hosaka T, Nakashima M, Ohmori T, Adachi M. Hirose T, et al. Among authors: shirai t. Cancer Chemother Pharmacol. 2007 Jul;60(2):267-74. doi: 10.1007/s00280-006-0369-4. Epub 2007 Feb 2. Cancer Chemother Pharmacol. 2007. PMID: 17273827 Clinical Trial.

7

Phase I study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer.

Okuda K, Hirose T, Ishida H, Kusumoto S, Sugiyama T, Ando K, Shirai T, Ohnishi T, Horichi N, Ohmori T, Adachi M. Okuda K, et al. Among authors: shirai t. Cancer Chemother Pharmacol. 2008 Apr;61(5):829-35. doi: 10.1007/s00280-007-0540-6. Epub 2007 Jun 23. Cancer Chemother Pharmacol. 2008. PMID: 17589845 Clinical Trial.

8

Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non-small cell lung cancer.

Hirose T, Yamaoka T, Ohnishi T, Sugiyama T, Kusumoto S, Shirai T, Okuda K, Ohmori T, Adachi M. Hirose T, et al. Among authors: shirai t. Psychooncology. 2009 May;18(5):483-9. doi: 10.1002/pon.1450. Psychooncology. 2009. PMID: 18942662

9

Phase II study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer.

Hirose T, Sugiyama T, Kusumoto S, Shirai T, Nakashima M, Yamaoka T, Okuda K, Ogura K, Ohnishi T, Ohmori T, Adachi M. Hirose T, et al. Among authors: shirai t. Anticancer Res. 2009 May;29(5):1733-8. Anticancer Res. 2009. PMID: 19443395 Free article. Clinical Trial.

10

Combination effect between bortezomib and tumor necrosis factor alpha on gefitinib-resistant non-small cell lung cancer cell lines.

Kusumoto S, Sugiyama T, Ando K, Hosaka T, Ishida H, Shirai T, Yamaoka T, Okuda K, Hirose T, Ohnishi T, Inoue F, Kanome T, Kadofuku T, Saijo N, Adachii M, Ohmori T. Kusumoto S, et al. Among authors: shirai t. Anticancer Res. 2009 Jun;29(6):2315-22. Anticancer Res. 2009. PMID: 19528497 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,264 results

Search Page

Filters